Cell Signaling Technology

Product Pathways - NF-kB Signaling

A20/TNFAIP3 Antibody #4625

Applications Reactivity Sensitivity MW (kDa) Source
W H Endogenous 82 Rabbit

Applications Key:  W=Western Blotting
Reactivity Key:  H=Human
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

A20/TNFAIP3 Antibody detects endogenous levels of total A20/TNFAIP3 protein.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Gly267 of human A20/TNFAIP3. Antibodies were purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from HeLa cells, untreated or treated with IL-1α (20 ng/ml for 2 hours), and from differentiated THP-1 cells (TPA #4174 80 nM overnight), untreated or treated with LPS (1 μg/ml overnight), using A20/TNFAIP3 Antibody.

Background

A20, also referred to as TNF-α-induced protein 3 (TNFAIP3), is cytokine-inducible protein that functions to inhibit apoptosis and activate NF-κB (1,2). It was first identified as a TNF-α inducible primary response gene in human umbilical vein endothelial cells, and encodes a 790-amino acid protein containing seven Cys2/Cys2-zinc finger motifs (3). Constitutive expression of A20 is observed in lymphoid tissues (4), but it is transiently expressed in a variety of cell types in response to inflammatory signals such as TNF-α (3,5), IL-1 (3,5), phorbol esters (6), and LPS (7). Expression of A20 can confer resistance to apoptosis and NF-κB activation triggered by these signals, probably through interference with TRAF (TNF receptor associated factor) family members (8,9), and interaction with the NF-κB inhibiting protein ABIN (10). Studies also show that A20 contains site-specific ubiquitin modifying activity that can contribute to its biological functions (11,12). The amino-terminus of A20 contains de-ubiquitinating (DUB) activity for Lys63 branches, such as those found in TRAF6 and RIP, while the carboxyl-terminus contains ubiquitin ligase (E3) activity for Lys48 branches of the same substrates and leads to their degradation (12).

  1. Beyaert, R. et al. (2000) Biochem Pharmacol 60, 1143-51.
  2. Lee, E.G. et al. (2000) Science 289, 2350-4.
  3. Dixit, V.M. et al. (1990) J Biol Chem 265, 2973-8.
  4. Tewari, M. et al. (1995) J Immunol 154, 1699-706.
  5. Jäättelä, M. et al. (1996) J Immunol 156, 1166-73.
  6. Laherty, C.D. et al. (1993) J Biol Chem 268, 5032-9.
  7. Hu, X. et al. (1998) Blood 92, 2759-65.
  8. Song, H.Y. et al. (1996) Proc Natl Acad Sci USA 93, 6721-5.
  9. Heyninck, K. and Beyaert, R. (1999) FEBS Lett 442, 147-50.
  10. Heyninck, K. et al. (1999) J Cell Biol 145, 1471-82.
  11. Evans, P.C. et al. (2004) Biochem J 378, 727-34.
  12. Lin, S.C. et al. (2008) J Mol Biol 376, 526-40.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

For Research Use Only. Not For Use In Diagnostic Procedures.

Products